Every SEC Form 3/4/5 on record for this filer (CIK 1644162) — 4 issuers, 15 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics, Inc. | Director | 2016-03-02 → 2026-06-05 | 13 | −$248,203 |
| CMMB | Chemomab Therapeutics Ltd. | Director | 2021-03-25 → 2026-03-31 | 5 | — |
| GANX | Gain Therapeutics, Inc. | Director | 2021-03-17 → 2025-06-25 | 5 | — |
| SAVA | CASSAVA SCIENCES INC | Director | 2023-12-08 → 2025-05-27 | 4 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| SRPT | 2025-03-12 | Sell | 2,491 | $99.64 | $248,203 | 27,812 |
3 of 4 issuers are covered and open a security page; the rest are on file here only.